Mesothelin (MSLN) promoter is hypomethylated in malignant mesothelioma, but its expression is not associated with methylation status of the promoter
Authors:
- Kazunori KajinoKKKazunori Kajino
- Shuji MomoseSMShuji Momose
- Akiko MasaokaAMAkiko Masaoka
- Keiichi SasaharaKSKeiichi Sasahara
- Kazu ShiomiKSKazu Shiomi
- Hiroshi IzumiHIHiroshi Izumi
- Masaaki AbeMAMasaaki Abe
- Naomi OhtsujiNONaomi Ohtsuji
- Tegexibaiyin WangTWTegexibaiyin Wang
- Okio HinoOHOkio Hino
- Hiroaki FujiiHFHiroaki Fujii
- 1 September 2010
- journal article
- Published by Elsevier in Human Pathology
- Vol. 41 (9) , 1330-1338
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinomaGynecologic Oncology, 2007
- Mesothelin Expression in Human Lung CancerClinical Cancer Research, 2007
- Detection and Quantitation of Serum Mesothelin, a Tumor Marker for Patients with Mesothelioma and Ovarian CancerClinical Cancer Research, 2006
- Mesothelin Is Overexpressed in Pancreaticobiliary Adenocarcinomas but Not in Normal Pancreas and Chronic PancreatitisAmerican Journal of Clinical Pathology, 2005
- Mesothelin-family proteins and diagnosis of mesotheliomaThe Lancet, 2003
- Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomasHuman Pathology, 2003
- Value of Mesothelin Immunostaining in the Diagnosis of MesotheliomaLaboratory Investigation, 2003
- Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.Proceedings of the National Academy of Sciences, 1996
- Molecular Cloning and Expression of Megakaryocyte Potentiating Factor cDNAJournal of Biological Chemistry, 1995
- Frequent expression of the tumor antigen cak1 in squamous‐cell carcinomasInternational Journal of Cancer, 1992